• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM Back to Search Results
Model Number AB2000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Chest Pain (1776)
Event Date 08/18/2022
Event Type  Death  
Manufacturer Narrative
Root cause of reported event has not yet been established.Investigation by manufacturer is currently in-process.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Event Description
On (b)(6) 2022, an 84-year-old male patient with an approximately 200-cc prostate size and with a clinical history of renal insufficiency and being on zocor medication underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).The aquablation procedure was completed without complications and the foley balloon catheter was clear when the patient left the operating room (or).On (b)(6) 2022, procept biorobotics corporation (procep) became aware that the patient expired on (b)(6) 2022.Through a follow-up conversation with the treating surgeon, procept confirmed that the aquablation procedure was successful without any complications and that the aquabeam robotic system performed as intended.Post-op, the patient passed out in the recovery room, likely due to traction coming off (creatinine levels were 12.7 to 5.9 mg/dl - normal range of 0.7 to 1.3 mg/dl for men).The patient was administered three (3) units of blood and taken back to the operating room with no bleeding observed.The next morning, one (1) day post-op, the patient began having chest pain and had st-segment elevation but was not taken to the catheter lab.On (b)(6) 2022 the patient expired.It was the treating surgeon's opinion that the patient expired due to cardiac reasons and indicated that the patient's relatives were going to decline an autopsy to be performed.
 
Manufacturer Narrative
H.10 additional manufacturer narrative: the aquabeam robotic system was not returned for investigation of this event and is currently in use at the user facility.The investigation consisted of a review of the information reported to procept, plus a review of device history record (dhr) and labeling.Three good faith efforts were made to obtain the log files for this event without success.A review of the device history record (dhr) ab2000-b rev.G/serial number: (b)(6) was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 3.Contraindications: do not use the aquabeam robotic system in patients who do not meet the indication for the system's intended use.Through a follow-up conversation with the treating physician, procept that the patient' death was unrelated to the aquablation procedure.Based on the information obtained through the treating surgeon plus a review of the dhr and labeling the event is considered not device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUABEAM ROBOTIC SYSTEM
Type of Device
FLUID JET REMOVAL SYSTEM
Manufacturer (Section D)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city CA 94065 1494
Manufacturer (Section G)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city CA 94065 1494
Manufacturer Contact
doria esquivel
900 island drive
suite 101
redwood city, CA 94065-1494
MDR Report Key15466395
MDR Text Key300402329
Report Number3012977056-2022-00125
Device Sequence Number1
Product Code PZP
UDI-Device IdentifierB614AB20001
UDI-Public+B614AB20001/$$721C00848/16D20210511G
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
DEN170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAB2000
Device Catalogue NumberAB2000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/26/2022
Initial Date FDA Received09/22/2022
Supplement Dates Manufacturer Received11/14/2022
Supplement Dates FDA Received11/15/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/11/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age84 YR
Patient SexMale
-
-